Annual FCF
-$15.84 M
+$3.28 M+17.16%
December 31, 2023
Summary
- As of March 6, 2025, INKT annual free cash flow is -$15.84 million, with the most recent change of +$3.28 million (+17.16%) on December 31, 2023.
- During the last 3 years, INKT annual FCF has fallen by -$7.40 million (-87.79%).
- INKT annual FCF is now -87.79% below its all-time high of -$8.43 million, reached on December 31, 2020.
Performance
INKT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$2.99 M
-$704.20 K-30.74%
September 30, 2024
Summary
- As of March 6, 2025, INKT quarterly free cash flow is -$2.99 million, with the most recent change of -$704.20 thousand (-30.74%) on September 30, 2024.
- Over the past year, INKT quarterly FCF has stayed the same.
- INKT quarterly FCF is now -75.96% below its all-time high of -$1.70 million, reached on December 31, 2021.
Performance
INKT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$10.86 M
+$1.24 M+10.22%
September 30, 2024
Summary
- As of March 6, 2025, INKT TTM free cash flow is -$10.86 million, with the most recent change of +$1.24 million (+10.22%) on September 30, 2024.
- Over the past year, INKT TTM FCF has stayed the same.
- INKT TTM FCF is now -155.72% below its all-time high of -$4.25 million, reached on March 31, 2021.
Performance
INKT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
INKT Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.2% | 0.0% | 0.0% |
| 3 y3 years | -87.8% | 0.0% | 0.0% |
| 5 y5 years | -3.0% | 0.0% | 0.0% |
INKT Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.1% | +17.2% | -76.0% | +47.2% | at high | +43.7% |
| 5 y | 5-year | -87.8% | +17.2% | -76.0% | +47.2% | -155.7% | +43.7% |
| alltime | all time | -87.8% | +17.2% | -76.0% | +47.2% | -155.7% | +43.7% |
MiNK Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.99 M(+30.7%) | -$10.86 M(-10.2%) |
| Jun 2024 | - | -$2.29 M(-9.9%) | -$12.10 M(-13.6%) |
| Mar 2024 | - | -$2.54 M(-16.3%) | -$14.00 M(-11.6%) |
| Dec 2023 | -$15.84 M(-17.2%) | -$3.04 M(-28.3%) | -$15.84 M(-8.8%) |
| Sep 2023 | - | -$4.23 M(+1.1%) | -$17.36 M(-7.7%) |
| Jun 2023 | - | -$4.19 M(-4.4%) | -$18.80 M(-2.6%) |
| Mar 2023 | - | -$4.38 M(-3.9%) | -$19.30 M(+1.0%) |
| Dec 2022 | -$19.12 M | -$4.56 M(-19.7%) | -$19.12 M(+17.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$5.67 M(+21.1%) | -$16.26 M(+14.6%) |
| Jun 2022 | - | -$4.69 M(+11.7%) | -$14.19 M(+9.0%) |
| Mar 2022 | - | -$4.20 M(+146.6%) | -$13.02 M(-0.4%) |
| Dec 2021 | -$13.08 M(+55.1%) | -$1.70 M(-52.8%) | -$13.08 M(+15.0%) |
| Sep 2021 | - | -$3.61 M(+2.5%) | -$11.37 M(+46.5%) |
| Jun 2021 | - | -$3.52 M(-17.2%) | -$7.77 M(+82.8%) |
| Mar 2021 | - | -$4.25 M | -$4.25 M |
| Dec 2020 | -$8.43 M(-45.1%) | - | - |
| Dec 2019 | -$15.37 M | - | - |
FAQ
- What is MiNK Therapeutics annual free cash flow?
- What is the all time high annual FCF for MiNK Therapeutics?
- What is MiNK Therapeutics annual FCF year-on-year change?
- What is MiNK Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for MiNK Therapeutics?
- What is MiNK Therapeutics quarterly FCF year-on-year change?
- What is MiNK Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for MiNK Therapeutics?
- What is MiNK Therapeutics TTM FCF year-on-year change?
What is MiNK Therapeutics annual free cash flow?
The current annual FCF of INKT is -$15.84 M
What is the all time high annual FCF for MiNK Therapeutics?
MiNK Therapeutics all-time high annual free cash flow is -$8.43 M
What is MiNK Therapeutics annual FCF year-on-year change?
Over the past year, INKT annual free cash flow has changed by +$3.28 M (+17.16%)
What is MiNK Therapeutics quarterly free cash flow?
The current quarterly FCF of INKT is -$2.99 M
What is the all time high quarterly FCF for MiNK Therapeutics?
MiNK Therapeutics all-time high quarterly free cash flow is -$1.70 M
What is MiNK Therapeutics quarterly FCF year-on-year change?
Over the past year, INKT quarterly free cash flow has changed by $0.00 (0.00%)
What is MiNK Therapeutics TTM free cash flow?
The current TTM FCF of INKT is -$10.86 M
What is the all time high TTM FCF for MiNK Therapeutics?
MiNK Therapeutics all-time high TTM free cash flow is -$4.25 M
What is MiNK Therapeutics TTM FCF year-on-year change?
Over the past year, INKT TTM free cash flow has changed by $0.00 (0.00%)